MC1253A1 - Derives amines de sucre utiles notamment comme medicaments - Google Patents

Derives amines de sucre utiles notamment comme medicaments

Info

Publication number
MC1253A1
MC1253A1 MC791365A MC1365A MC1253A1 MC 1253 A1 MC1253 A1 MC 1253A1 MC 791365 A MC791365 A MC 791365A MC 1365 A MC1365 A MC 1365A MC 1253 A1 MC1253 A1 MC 1253A1
Authority
MC
Monaco
Prior art keywords
trestatin
brown
trestatins
trestatine
isp
Prior art date
Application number
MC791365A
Other languages
English (en)
French (fr)
Inventor
K Watanabe
K Ogawa
Y Suhara
K Yokose
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MC1253A1 publication Critical patent/MC1253A1/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20Carbocyclic rings
    • C07H15/22Cyclohexane rings, substituted by nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/99Enzyme inactivation by chemical treatment
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/26Preparation of nitrogen-containing carbohydrates

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
MC791365A 1978-02-14 1979-02-13 Derives amines de sucre utiles notamment comme medicaments MC1253A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB583478 1978-02-14

Publications (1)

Publication Number Publication Date
MC1253A1 true MC1253A1 (fr) 1980-01-14

Family

ID=9803510

Family Applications (1)

Application Number Title Priority Date Filing Date
MC791365A MC1253A1 (fr) 1978-02-14 1979-02-13 Derives amines de sucre utiles notamment comme medicaments

Country Status (26)

Country Link
US (1) US4273765A (cg-RX-API-DMAC10.html)
EP (1) EP0003616B1 (cg-RX-API-DMAC10.html)
JP (1) JPS54163511A (cg-RX-API-DMAC10.html)
AR (1) AR219150A1 (cg-RX-API-DMAC10.html)
AT (1) AT367451B (cg-RX-API-DMAC10.html)
AU (1) AU527318B2 (cg-RX-API-DMAC10.html)
CA (1) CA1121290A (cg-RX-API-DMAC10.html)
DE (2) DE2962165D1 (cg-RX-API-DMAC10.html)
DK (1) DK149599C (cg-RX-API-DMAC10.html)
ES (1) ES477653A1 (cg-RX-API-DMAC10.html)
FI (1) FI63062C (cg-RX-API-DMAC10.html)
FR (1) FR2416901A1 (cg-RX-API-DMAC10.html)
GR (1) GR72817B (cg-RX-API-DMAC10.html)
HU (1) HU181442B (cg-RX-API-DMAC10.html)
IE (1) IE47916B1 (cg-RX-API-DMAC10.html)
IL (1) IL56626A0 (cg-RX-API-DMAC10.html)
LU (1) LU80906A1 (cg-RX-API-DMAC10.html)
MC (1) MC1253A1 (cg-RX-API-DMAC10.html)
NL (1) NL7901182A (cg-RX-API-DMAC10.html)
NO (1) NO153011C (cg-RX-API-DMAC10.html)
NZ (1) NZ189625A (cg-RX-API-DMAC10.html)
PH (1) PH15084A (cg-RX-API-DMAC10.html)
PT (1) PT69218A (cg-RX-API-DMAC10.html)
SE (1) SE7901276L (cg-RX-API-DMAC10.html)
YU (1) YU41437B (cg-RX-API-DMAC10.html)
ZA (1) ZA79528B (cg-RX-API-DMAC10.html)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0056194B1 (en) * 1981-01-05 1984-09-12 Takeda Chemical Industries, Ltd. N-substituted pseudo-aminosugars, their production and use
JPS57146713A (en) * 1981-03-09 1982-09-10 Akira Endo Hypoglycemic
US4595678A (en) * 1982-03-19 1986-06-17 Takeda Chemical Industries, Ltd. N-substituted pseudo-aminosugars and pharmaceutical compositions containing same
US4678812A (en) * 1986-05-30 1987-07-07 E. I. Du Pont De Nemours And Company Trehalose as stabilizer and tableting excipient
US4762857A (en) * 1986-05-30 1988-08-09 E. I. Du Pont De Nemours And Company Trehalose as stabilizer and tableting excipient
US4885361A (en) * 1987-07-31 1989-12-05 Hoffmann-La Roche Inc. Sulfated oligosaccharides
EP0559795B1 (en) * 1990-11-30 1995-12-27 Monoclonetics International, Inc. Methods for the diagnosis of chronic lower back and cervical pain
CA2128044C (en) * 1993-08-05 2007-02-20 Klaus-Dieter Bremer Pharmaceutical compositions comprising a glucosidase and/or amylase inhibitor, and a lipase inhibitor
US7022684B2 (en) * 2000-05-24 2006-04-04 Pfizer Inc. Treatment of rumen acidosis with α-amylase inhibitors
ATE343391T1 (de) * 2000-05-24 2006-11-15 Pfizer Behandlung von pansenacidose mit amylasehemmern
JP2007512359A (ja) 2003-11-19 2007-05-17 メタバシス・セラピューティクス・インコーポレイテッド 新規なリン含有甲状腺ホルモン様物質
US7262318B2 (en) * 2004-03-10 2007-08-28 Pfizer, Inc. Substituted heteroaryl- and phenylsulfamoyl compounds
US20050288340A1 (en) * 2004-06-29 2005-12-29 Pfizer Inc Substituted heteroaryl- and phenylsulfamoyl compounds
MX2007005137A (es) * 2004-11-23 2007-06-22 Warner Lambert Co Derivados del acido 7-(2h-pyrazol-3-il)-3, 5-dihidroxi-heptanoico como inhibidores de hmg co-a reductasa para el tratamiento de lipidemia.
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
WO2008070496A2 (en) 2006-12-01 2008-06-12 Bristol-Myers Squibb Company N- ( (3-benzyl) -2, 2- (bis-phenyl) -propan-1-amine derivatives as cetp inhibitors for the treatment of atherosclerosis and cardiovascular diseases
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
EP2170930B3 (en) 2007-06-04 2013-10-02 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US20110105420A1 (en) * 2008-04-11 2011-05-05 Astellas Pharma Inc. Aminosugar compound and process for production thereof
JP2011522828A (ja) 2008-06-04 2011-08-04 シナジー ファーマシューティカルズ インコーポレイテッド 胃腸障害、炎症、癌、およびその他の障害の治療のために有用なグアニル酸シクラーゼのアゴニスト
EP2321341B1 (en) 2008-07-16 2017-02-22 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
US20120046364A1 (en) 2009-02-10 2012-02-23 Metabasis Therapeutics, Inc. Novel Sulfonic Acid-Containing Thyromimetics, and Methods for Their Use
JP2013528172A (ja) 2010-05-21 2013-07-08 ファイザー・インク 2−フェニルベンゾイルアミド
US20130156720A1 (en) 2010-08-27 2013-06-20 Ironwood Pharmaceuticals, Inc. Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
US20130345392A1 (en) 2011-03-04 2013-12-26 Pfizer Inc Edn3-like peptides and uses thereof
WO2013133685A1 (en) 2012-03-09 2013-09-12 Biotropics Malaysia Berhad Extract formulations of rhodamnia cinerea and uses thereof
CA2905435A1 (en) 2013-03-15 2014-09-25 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
US9708367B2 (en) 2013-03-15 2017-07-18 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase and their uses
BR112015026513A2 (pt) 2013-04-17 2017-07-25 Pfizer derivados de n-piperidin-3-ilbenzamida para tratar as doenças cardiovasculares
RS65632B1 (sr) 2013-06-05 2024-07-31 Bausch Health Ireland Ltd Ultra-prečišćeni agonisti guanilat-ciklaze c, postupak njihove pripreme i upotrebe
CN113121450A (zh) 2014-08-29 2021-07-16 Tes制药有限责任公司 α-氨基-β-羧基粘康酸半醛脱羧酶抑制剂
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
US20180134667A1 (en) 2016-10-14 2018-05-17 TES Pharma S.r.I. Inhibitors of alpha-amino-beta-carboxymuconic acid semialdehyde decarboxylase
IL283182B2 (en) 2018-11-20 2025-10-01 Tes Pharma S R L Alpha-amino-beta-carboxymuconic acid semialdehyde decarboxylase inhibitors
MA54261B1 (fr) 2019-01-18 2025-03-28 Astrazeneca Ab Inhibiteurs de pcsk9 et leurs procédés d'utilisation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2064092C2 (de) * 1970-12-28 1983-06-01 Bayer Ag, 5090 Leverkusen Inhibitoren für Glykosidhydrolasen aus Actinomyceten
DE2347782C3 (de) * 1973-09-22 1979-10-11 Bayer Ag, 5090 Leverkusen Aminozuckerderivate, Verfahren zu ihrer Herstellung sowie diese Verbindungen enthaltende Arzneimittel
US4062950A (en) * 1973-09-22 1977-12-13 Bayer Aktiengesellschaft Amino sugar derivatives
US4065557A (en) * 1974-03-21 1977-12-27 Bayer Aktiengesellschaft Amino sugars and their use in improving the meat:fat ratio in animals
USRE29903E (en) 1975-03-19 1979-02-06 American Cyanamid Company Antibacterial antibiotics AM31α, AM31β and AM31γ
DE2614393C3 (de) * 1976-04-02 1980-04-03 Bayer Ag, 5090 Leverkusen Aminozucker-Derivate und diese Verbindungen enthaltende Arzneimittel

Also Published As

Publication number Publication date
AU4402879A (en) 1979-08-23
FI63062B (fi) 1982-12-31
IE47916B1 (en) 1984-07-25
US4273765A (en) 1981-06-16
YU41437B (en) 1987-06-30
DE2905649A1 (de) 1979-08-16
JPS643877B2 (cg-RX-API-DMAC10.html) 1989-01-23
DE2962165D1 (en) 1982-03-25
FI790486A7 (fi) 1979-08-15
SE7901276L (sv) 1979-08-15
YU34879A (en) 1983-01-21
ZA79528B (en) 1980-02-27
AU527318B2 (en) 1983-02-24
CA1121290A (en) 1982-04-06
LU80906A1 (de) 1980-09-24
EP0003616A3 (en) 1979-09-05
NO790469L (no) 1979-08-15
DK149599B (da) 1986-08-04
GR72817B (cg-RX-API-DMAC10.html) 1983-12-06
IL56626A0 (en) 1979-05-31
FR2416901A1 (fr) 1979-09-07
DK149599C (da) 1987-06-01
HU181442B (en) 1983-07-28
AR219150A1 (es) 1980-07-31
PH15084A (en) 1982-07-02
IE790274L (en) 1979-08-14
AT367451B (de) 1982-07-12
NZ189625A (en) 1981-05-01
FI63062C (fi) 1983-04-11
EP0003616A2 (de) 1979-08-22
NO153011C (no) 1986-01-02
ES477653A1 (es) 1980-03-01
EP0003616B1 (de) 1982-02-24
FR2416901B1 (cg-RX-API-DMAC10.html) 1980-10-24
NL7901182A (nl) 1979-08-16
PT69218A (en) 1979-03-01
ATA108879A (de) 1981-11-15
JPS54163511A (en) 1979-12-26
NO153011B (no) 1985-09-23
DK61179A (da) 1979-08-15

Similar Documents

Publication Publication Date Title
MC1253A1 (fr) Derives amines de sucre utiles notamment comme medicaments
AU612189B2 (en) New antibiotics, benanomicins a and b and dexylosylbenanomicin b, and production and uses thereof
FR2555586A1 (fr) Complexe antibiotique bbm-2478
CH637160A5 (fr) Procede de fabrication de glucosides anthracyclines.
EP0612742A1 (en) A physiologically active bisindole-pyrrole derivative
KR920001448B1 (ko) Bbm-2478 항생제 착화합물
US4550159A (en) Anthracycline compounds
FR2517697A1 (fr) Nouveaux aminoglycosides antibiotiques appeles saccharocines et leur production
MC1615A1 (fr) Antibiotiques
JP2742586B2 (ja) Tan−1030aおよびその誘導体,これらの製造法ならびに用途
FR2472611A1 (fr) Antibiotiques, procedes pour leur production et agent antimycotique en contenant
FR2490223A1 (fr) Nouveau peptide, son procede de preparation et culture du microorganisme utilise dans ce procede
US5109122A (en) Antibiotics, dexylosylbenanomicin B
US5117052A (en) Physiologically active substances, benastatins a and b, and production and use thereof
JP3759207B2 (ja) 抗菌剤及び医薬組成物
CH646982A5 (fr) Derives de tallysomycine, leur procede de production et medicament les contenant.
HU194314B (en) Process for preparing new, alpha-glucosidase inhibiting pseudooligosaccharides
EP0118732A2 (en) An anthracycline compound, a process for the production thereof, a pharmaceutical composition containing the same and its use as a medicament
EP1753858B1 (fr) Nouvelle souche saccharothrix et ses antibiotiques derives, notamment mutactimycines et aldgamycines
KR790001709B1 (ko) 아미노-슈가 화합물의 제조방법
EP0432697A2 (en) BU-4146T antibiotic
DK167006B1 (da) 5-hydroxy-1,4-naftoquinoner, fremgangsmaade til fremstilling deraf samt antifibrotisk praeparat indeholdende en saadan forbindelse
EP0185979A1 (en) A novel substance having anti-tumor activity, a microbiological process for the preparation thereof and its use as a medicament
EP0179751B1 (fr) Ionophore polyéther, son procédé de préparation et son utilisation
BE859236A (fr) Nouveaux antibiotiques anti-fumeurs, de type anthracycline

Legal Events

Date Code Title Description
YP Annual fee paid